Detail page

Knowledge Web

Person

Annika Spottke

Ärztin

Name	Annika Spottke
Place	Bonn (Wirkungsort) Deutschland
Academic degree	Dr.
Profession	Ärztin (characteristic profession)
Related	Deutsches Zentrum für Neurodegenerative Erkrankungen Klinik und Poliklinik für Neurologie (Bonn)
Source	Webseite: https://www.dzne.de/forschung/forschungsbereiche/klinische-forschung/forschungsgruppen/spottke/curriculum-vitae/ (Stand: 26.09.2024)
Record type	Person
GND-Identifier	1343218721
Record ID	1343218721
Involved in show all GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA) Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve Fronto-striatal alterations correlate with apathy severity in behavioral variant frontotemporal dementia The comorbidity and co-medication profile of patients with progressive supranuclear palsy Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2 Patient‐related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE The comorbidity and co-medication profile of patients with progressive supranuclear palsy Musical Activity During Life Is Associated With Multi-Domain Cognitive and Brain Benefits in Older Adults Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease A microRNA signature that correlates with cognition and is a target against cognitive decline Outcomes of SARS-CoV-2 infections in patients with neurodegenerative diseases in the LEOSS cohort Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease based on multicenter diffusion tensor imaging No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) Cognitive impairment in 873 patients with idiopathic Parkinson’s disease : Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD) Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Annika Spottke

GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)

Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation

Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices

The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve

Fronto-striatal alterations correlate with apathy severity in behavioral variant frontotemporal dementia

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study

Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2

Patient‐related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

Musical Activity During Life Is Associated With Multi-Domain Cognitive and Brain Benefits in Older Adults

Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

A microRNA signature that correlates with cognition and is a target against cognitive decline

Outcomes of SARS-CoV-2 infections in patients with neurodegenerative diseases in the LEOSS cohort

Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study

Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease based on multicenter diffusion tensor imaging

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)

Cognitive impairment in 873 patients with idiopathic Parkinson’s disease : Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD)

Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)